Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease which confers an increased risk of malignant tumour development. Relapsing remitting multiple sclerosis (RRMS) is an inflammatory demyelinating disease of the central nervous system. The coexistence of multiple sclerosis...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-02-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2190 |
id |
doaj-90872ac61e7b416b9f46f642408a38af |
---|---|
record_format |
Article |
spelling |
doaj-90872ac61e7b416b9f46f642408a38af2021-02-08T08:26:14ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942021-02-0110.12890/2021_0021901806Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)Silvia Ciotti0Antonella Cometa1Claudia De Carlo2Giancarlo Martini3Andrea Marona4Laura Filippetti5Diego Carducci6Silvano Baratta7Mauro Zampolini8Francesco Corea9USL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation, S.M. Stella, Orvieto, ItalyUSL Umbria 2, Department of Rehabilitation, Domus Gratiae, Terni, ItalyDepartment of Rehabilitation, Ospedale di Cascia, ItalyUSL Umbria 2, Department of Neuroradiology, Ospedale S.G. Battista di Foligno, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista di Foligno, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista di Foligno, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista di Foligno, ItalyNeurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease which confers an increased risk of malignant tumour development. Relapsing remitting multiple sclerosis (RRMS) is an inflammatory demyelinating disease of the central nervous system. The coexistence of multiple sclerosis and NF1 is rare but has been reported. Here, we describe the case of a 31-year-old man with NF1 and subacute walking problems with proximal pain in the lower limbs who was successfully treated with natalizumab.https://www.ejcrim.com/index.php/EJCRIM/article/view/2190multiple sclerosisneurofibromatosis 1neurorehabilitationnatalizumabcase report |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Silvia Ciotti Antonella Cometa Claudia De Carlo Giancarlo Martini Andrea Marona Laura Filippetti Diego Carducci Silvano Baratta Mauro Zampolini Francesco Corea |
spellingShingle |
Silvia Ciotti Antonella Cometa Claudia De Carlo Giancarlo Martini Andrea Marona Laura Filippetti Diego Carducci Silvano Baratta Mauro Zampolini Francesco Corea Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) European Journal of Case Reports in Internal Medicine multiple sclerosis neurofibromatosis 1 neurorehabilitation natalizumab case report |
author_facet |
Silvia Ciotti Antonella Cometa Claudia De Carlo Giancarlo Martini Andrea Marona Laura Filippetti Diego Carducci Silvano Baratta Mauro Zampolini Francesco Corea |
author_sort |
Silvia Ciotti |
title |
Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) |
title_short |
Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) |
title_full |
Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) |
title_fullStr |
Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) |
title_full_unstemmed |
Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) |
title_sort |
neurofibromatosis type 1 with highly active relapsing-remitting multiple sclerosis (rrms) |
publisher |
SMC MEDIA SRL |
series |
European Journal of Case Reports in Internal Medicine |
issn |
2284-2594 |
publishDate |
2021-02-01 |
description |
Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease which confers an increased risk of malignant tumour development. Relapsing remitting multiple sclerosis (RRMS) is an inflammatory demyelinating disease of the central nervous system. The coexistence of multiple sclerosis and NF1 is rare but has been reported. Here, we describe the case of a 31-year-old man with NF1 and subacute walking problems with proximal pain in the lower limbs who was successfully treated with natalizumab. |
topic |
multiple sclerosis neurofibromatosis 1 neurorehabilitation natalizumab case report |
url |
https://www.ejcrim.com/index.php/EJCRIM/article/view/2190 |
work_keys_str_mv |
AT silviaciotti neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT antonellacometa neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT claudiadecarlo neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT giancarlomartini neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT andreamarona neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT laurafilippetti neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT diegocarducci neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT silvanobaratta neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT maurozampolini neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms AT francescocorea neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms |
_version_ |
1724280306275450880 |